|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Apoptosis
|
 |
|
Title:
|
 |
Crystal structure of the complex between the n-terminal domain of tradd and the traf domain of traf2
|
|
Structure:
|
 |
Tumor necrosis factor receptor type 1 associated death domain protein. Chain: a. Fragment: n-terminal domain. Synonym: tradd, tnfr1-associated death domain protein. Engineered: yes. Tumor necrosis factor receptor-associated protein. Chain: b. Fragment: traf domain.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Biol. unit:
|
 |
Hexamer (from
)
|
|
Resolution:
|
 |
|
2.00Å
|
R-factor:
|
0.229
|
R-free:
|
0.261
|
|
|
Authors:
|
 |
Y.C.Park,H.Ye,C.Hsia,D.Segal,R.Rich,H.-C.Liou,D.Myszka,H.Wu
|
Key ref:
|
 |
Y.C.Park
et al.
(2000).
A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction.
Cell,
101,
777-787.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
06-Jun-00
|
Release date:
|
06-Sep-00
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain B:
E.C.2.3.2.27
- RING-type E3 ubiquitin transferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N6- ubiquitinyl-[acceptor protein]-L-lysine
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Cell
101:777-787
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction.
|
|
Y.C.Park,
H.Ye,
C.Hsia,
D.Segal,
R.L.Rich,
H.C.Liou,
D.G.Myszka,
H.Wu.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
TRAF proteins are major mediators for the cell activation, cell survival, and
antiapoptotic functions of the TNF receptor superfamily. They can be recruited
to activated TNF receptors either by direct interactions with the receptors or
indirectly via the adaptor protein TRADD. We now report the structure of the
TRADD-TRAF2 complex, which is highly distinct from receptor-TRAF2 interactions.
This interaction is significantly stronger and we show by an in vivo signaling
assay that TRAF2 signaling is more readily initiated by TRADD than by direct
receptor-TRAF2 interactions. TRADD is specific for TRAF1 and TRAF2, which
ensures the recruitment of clAPs for the direct inhibition of caspase activation
in the signaling complex. The stronger affinity and unique specificity of the
TRADD-TRAF2 interaction are crucial for the suppression of apoptosis and provide
a mechanistic basis for the perturbation of TRAF recruitment in sensitizing cell
death induction.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Structural Overview of TRADD-N and the
TRADD-N/TRAF2 Complex(A) Ribbon representation of TRADD-N,
showing the two-layer arrangement of the α-β sandwich. Helices
are colored yellow (A-F), β strands blue (1–4), and loops
green. The β sheet is entirely antiparallel and slightly
twisted with a strand order of β2, β3, β1, and β4. There are
two helices each in the β1-β2 and β3-β4 cross-over
connections while the β2-β3 connection is hairpin-like. The
remaining two helices (E and F) are near the carboxyl terminus
of the domain; the loop in between (EF loop) partly covers one
end of the exposed face of the β sheet. A single hydrophobic
core is present in TRADD-N between the buried face of the β
sheet and the opposing α helices. The closed nature of this
hydrophobic core supports that this domain folds independently
of the carboxy-terminal death domain.(B and C) Ribbon
representations of the TRADD-N/TRAF2 complex, showing with the
3-fold axis vertical in (B) and into the page in (C). Three
molecules of TRADD-N are shown respectively in magenta, red, and
yellow. The protomers of the trimeric TRAF domain of TRAF2 are
shown respectively in cyan, green, and dark blue. The death
domain of TRADD (TRADD-C) is proposed to be locate above the
C-terminal helix of TRADD-N in (B).(D) A hypothetical
molecular arrangement in the signaling complex of TNFR1 and
related death receptors. The cell membrane is represented in
yellow. The trimeric TNFα, shown by ovals, mediates TNFR1
trimerization. TNFR1 is shown by straight rectangles, while FADD
and RIP are shown by bent rectangles. Death domains in TNFR1,
TRADD (labeled as TRADD-C), FADD, and RIP are shaded in gray.
TRADD-N and the TRAF domain of TRAF2 are highlighted using the
same color-coding in (B) and (C). cIAPs (oval shape) are
recruited by TRAF2 and shown to inhibit caspase activation by
this signaling complex. For clarity, only single molecules of
FADD and RIP are shown, even though they are expected to
multimerize in the signaling complex.
|
 |
Figure 3.
Figure 3. Energetics of the Interaction(A) Mapping of
structural features onto the TRADD-N sequence. The first line is
human TRADD and the second line is mouse TRADD with identical
residues shown as dashes. Solvent accessibility of each TRADD-N
residue when the TRAF2 structure is pulled away is shaded below
the sequences. Residues involved in TRAF2 interaction are
colored based on their total surface area burials and those
completely buried at the interface are labeled by asterisks.
TRADD residues involved in TRAF2 interaction are almost entirely
identical between the human and mouse sequences, suggesting a
functional conservation among the mammalian species.(B)
Characterization of the interactions of wild-type and mutant
TRADD-N with wild-type TRAF domain of TRAF2 using biosensor
analysis. The dissociation constants (K[D]) in μM and relative
to the wild-type interaction are shown, as well as the
calculated ΔΔG of the mutational effects (25°C).(C)
TRAF2-interacting surface of TRADD-N. Region I is shown in cold
colors (light blue, blue, dark blue, green, and purple) and
region II in different shades of red. Colors for each mutated
residue follow the same text color in (B).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Cell
(2000,
101,
777-787)
copyright 2000.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Zheng,
Q.Yin,
and
H.Wu
(2011).
Structural studies of NF-κB signaling.
|
| |
Cell Res,
21,
183-195.
|
 |
|
|
|
|
 |
H.Wajant,
and
P.Scheurich
(2011).
TNFR1-induced activation of the classical NF-κB pathway.
|
| |
FEBS J,
278,
862-876.
|
 |
|
|
|
|
 |
A.W.Ho,
and
S.L.Gaffen
(2010).
IL-17RC: a partner in IL-17 signaling and beyond.
|
| |
Semin Immunopathol,
32,
33-42.
|
 |
|
|
|
|
 |
F.S.Carneiro,
R.C.Webb,
and
R.C.Tostes
(2010).
Emerging role for TNF-α in erectile dysfunction.
|
| |
J Sex Med,
7,
3823-3834.
|
 |
|
|
|
|
 |
J.Silke,
and
R.Brink
(2010).
Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs.
|
| |
Cell Death Differ,
17,
35-45.
|
 |
|
|
|
|
 |
K.Z.Wang,
D.L.Galson,
and
P.E.Auron
(2010).
TRAF6 is autoinhibited by an intramolecular interaction which is counteracted by trans-ubiquitination.
|
| |
J Cell Biochem,
110,
763-771.
|
 |
|
|
|
|
 |
S.Sethu,
and
A.J.Melendez
(2010).
New developments on the TNFα-mediated signalling pathways.
|
| |
Biosci Rep,
31,
63-76.
|
 |
|
|
|
|
 |
D.Wang,
R.B.Montgomery,
L.J.Schmidt,
E.A.Mostaghel,
H.Huang,
P.S.Nelson,
and
D.J.Tindall
(2009).
Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression.
|
| |
Cancer Res,
69,
9448-9456.
|
 |
|
|
|
|
 |
E.Petsalaki,
A.Stark,
E.García-Urdiales,
and
R.B.Russell
(2009).
Accurate prediction of peptide binding sites on protein surfaces.
|
| |
PLoS Comput Biol,
5,
e1000335.
|
 |
|
|
|
|
 |
K.Blackwell,
L.Zhang,
G.S.Thomas,
S.Sun,
H.Nakano,
and
H.Habelhah
(2009).
TRAF2 phosphorylation modulates tumor necrosis factor alpha-induced gene expression and cell resistance to apoptosis.
|
| |
Mol Cell Biol,
29,
303-314.
|
 |
|
|
|
|
 |
Q.Yin,
B.Lamothe,
B.G.Darnay,
and
H.Wu
(2009).
Structural basis for the lack of E2 interaction in the RING domain of TRAF2.
|
| |
Biochemistry,
48,
10558-10567.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Kieser
(2008).
Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1.
|
| |
Biol Chem,
389,
1261-1271.
|
 |
|
|
|
|
 |
F.F.Angileri,
M.Aguennouz,
A.Conti,
D.La Torre,
S.Cardali,
R.Crupi,
C.Tomasello,
A.Germanò,
G.Vita,
and
F.Tomasello
(2008).
Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
|
| |
Cancer,
112,
2258-2266.
|
 |
|
|
|
|
 |
M.J.Dechant,
C.G.Scheuerpflug,
E.Pauly,
J.van der Werff Ten Bosch,
K.M.Debatin,
and
J.Fellenberg
(2008).
Screening, identification, and functional analysis of three novel missense mutations in the TRADD gene in children with ALL and ALPS.
|
| |
Pediatr Blood Cancer,
51,
616-620.
|
 |
|
|
|
|
 |
F.K.Chan
(2007).
Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling.
|
| |
Cytokine,
37,
101-107.
|
 |
|
|
|
|
 |
A.Franzke,
R.Geffers,
J.K.Hunger,
S.Pförtner,
W.Piao,
P.Ivanyi,
J.Grosse,
M.Probst-Kepper,
A.Ganser,
and
J.Buer
(2006).
Identification of novel regulators in T-cell differentiation of aplastic anemia patients.
|
| |
BMC Genomics,
7,
263.
|
 |
|
|
|
|
 |
E.Varfolomeev,
S.M.Wayson,
V.M.Dixit,
W.J.Fairbrother,
and
D.Vucic
(2006).
The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
|
| |
J Biol Chem,
281,
29022-29029.
|
 |
|
|
|
|
 |
P.J.Kundrotas,
and
E.Alexov
(2006).
Electrostatic properties of protein-protein complexes.
|
| |
Biophys J,
91,
1724-1736.
|
 |
|
|
|
|
 |
A.Conti,
M.Ageunnouz,
D.La Torre,
S.Cardali,
F.F.Angileri,
C.Buemi,
C.Tomasello,
D.G.Iacopino,
D.D'Avella,
G.Vita,
and
F.Tomasello
(2005).
Expression of the tumor necrosis factor receptor-associated factors 1 and 2 and regulation of the nuclear factor-kappaB antiapoptotic activity in human gliomas.
|
| |
J Neurosurg,
103,
873-881.
|
 |
|
|
|
|
 |
A.P.Grech,
S.Gardam,
T.Chan,
R.Quinn,
R.Gonzales,
A.Basten,
and
R.Brink
(2005).
Tumor necrosis factor receptor 2 (TNFR2) signaling is negatively regulated by a novel, carboxyl-terminal TNFR-associated factor 2 (TRAF2)-binding site.
|
| |
J Biol Chem,
280,
31572-31581.
|
 |
|
|
|
|
 |
S.Huber
(2004).
T cells in coxsackievirus-induced myocarditis.
|
| |
Viral Immunol,
17,
152-164.
|
 |
|
|
|
|
 |
A.G.Eliopoulos,
E.R.Waites,
S.M.Blake,
C.Davies,
P.Murray,
and
L.S.Young
(2003).
TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.
|
| |
J Virol,
77,
1316-1328.
|
 |
|
|
|
|
 |
C.L.Galindo,
J.Sha,
D.A.Ribardo,
A.A.Fadl,
L.Pillai,
and
A.K.Chopra
(2003).
Identification of Aeromonas hydrophila cytotoxic enterotoxin-induced genes in macrophages using microarrays.
|
| |
J Biol Chem,
278,
40198-40212.
|
 |
|
|
|
|
 |
G.Xu,
R.L.Rich,
C.Steegborn,
T.Min,
Y.Huang,
D.G.Myszka,
and
H.Wu
(2003).
Mutational analyses of the p35-caspase interaction. A bowstring kinetic model of caspase inhibition by p35.
|
| |
J Biol Chem,
278,
5455-5461.
|
 |
|
|
|
|
 |
I.El Yazidi-Belkoura,
E.Adriaenssens,
L.Dollé,
S.Descamps,
and
H.Hondermarck
(2003).
Tumor necrosis factor receptor-associated death domain protein is involved in the neurotrophin receptor-mediated antiapoptotic activity of nerve growth factor in breast cancer cells.
|
| |
J Biol Chem,
278,
16952-16956.
|
 |
|
|
|
|
 |
J.M.Zapata
(2003).
TNF-receptor-associated factors as targets for drug development.
|
| |
Expert Opin Ther Targets,
7,
411-425.
|
 |
|
|
|
|
 |
T.Pawson,
and
P.Nash
(2003).
Assembly of cell regulatory systems through protein interaction domains.
|
| |
Science,
300,
445-452.
|
 |
|
|
|
|
 |
Y.Deng,
X.Ren,
L.Yang,
Y.Lin,
and
X.Wu
(2003).
A JNK-dependent pathway is required for TNFalpha-induced apoptosis.
|
| |
Cell,
115,
61-70.
|
 |
|
|
|
|
 |
A.Krippner-Heidenreich,
F.Tübing,
S.Bryde,
S.Willi,
G.Zimmermann,
and
P.Scheurich
(2002).
Control of receptor-induced signaling complex formation by the kinetics of ligand/receptor interaction.
|
| |
J Biol Chem,
277,
44155-44163.
|
 |
|
|
|
|
 |
C.Li,
C.Z.Ni,
M.L.Havert,
E.Cabezas,
J.He,
D.Kaiser,
J.C.Reed,
A.C.Satterthwait,
G.Cheng,
and
K.R.Ely
(2002).
Downstream regulator TANK binds to the CD40 recognition site on TRAF3.
|
| |
Structure,
10,
403-411.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.L.Boone,
E.G.Lee,
S.Libby,
P.J.Gibson,
M.Chien,
F.Chan,
M.Madonia,
P.R.Burkett,
and
A.Ma
(2002).
Recent advances in understanding NF-kappaB regulation.
|
| |
Inflamm Bowel Dis,
8,
201-212.
|
 |
|
|
|
|
 |
G.Polekhina,
C.M.House,
N.Traficante,
J.P.Mackay,
F.Relaix,
D.A.Sassoon,
M.W.Parker,
and
D.D.Bowtell
(2002).
Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-alpha signaling.
|
| |
Nat Struct Biol,
9,
68-75.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Ye,
M.Cirilli,
and
H.Wu
(2002).
The use of construct variation and diffraction data analysis in the crystallization of the TRAF domain of human tumor necrosis factor receptor associated factor 6.
|
| |
Acta Crystallogr D Biol Crystallogr,
58,
1886-1888.
|
 |
|
|
|
|
 |
J.C.Reed,
and
K.R.Ely
(2002).
Degrading liaisons: Siah structure revealed.
|
| |
Nat Struct Biol,
9,
8.
|
 |
|
|
|
|
 |
K.J.Park,
S.H.Choi,
S.Y.Lee,
S.B.Hwang,
and
M.M.Lai
(2002).
Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor alpha-stimulated nuclear factor kappa B activation.
|
| |
J Biol Chem,
277,
13122-13128.
|
 |
|
|
|
|
 |
P.Xia,
L.Wang,
P.A.Moretti,
N.Albanese,
F.Chai,
S.M.Pitson,
R.J.D'Andrea,
J.R.Gamble,
and
M.A.Vadas
(2002).
Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling.
|
| |
J Biol Chem,
277,
7996-8003.
|
 |
|
|
|
|
 |
Y.C.Xu,
R.F.Wu,
Y.Gu,
Y.S.Yang,
M.C.Yang,
F.E.Nwariaku,
and
L.S.Terada
(2002).
Involvement of TRAF4 in oxidative activation of c-Jun N-terminal kinase.
|
| |
J Biol Chem,
277,
28051-28057.
|
 |
|
|
|
|
 |
E.M.Gravallese,
D.L.Galson,
S.R.Goldring,
and
P.E.Auron
(2001).
The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption.
|
| |
Arthritis Res,
3,
6.
|
 |
|
|
|
|
 |
H.Wajant,
and
P.Scheurich
(2001).
Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling.
|
| |
Int J Biochem Cell Biol,
33,
19-32.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2001).
BIACORE J: a new platform for routine biomolecular interaction analysis.
|
| |
J Mol Recognit,
14,
223-228.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2001).
Survey of the year 2000 commercial optical biosensor literature.
|
| |
J Mol Recognit,
14,
273-294.
|
 |
|
|
|
|
 |
V.Baud,
and
M.Karin
(2001).
Signal transduction by tumor necrosis factor and its relatives.
|
| |
Trends Cell Biol,
11,
372-377.
|
 |
|
|
|
|
 |
E.Y.Jones
(2000).
The tumour necrosis factor receptor family: life or death choices.
|
| |
Curr Opin Struct Biol,
10,
644-648.
|
 |
|
|
|
|
 |
K.F.Chan,
M.R.Siegel,
and
J.M.Lenardo
(2000).
Signaling by the TNF receptor superfamily and T cell homeostasis.
|
| |
Immunity,
13,
419-422.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |